Search

everythinglearnresearchcommunity

for

Search:↓

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Using isotretinoin gel and minoxidil solution together effectively regrows hair in most people with patchy hair loss.

Rubbing calcipotriol on the skin works better than taking vitamin D pills for treating mild to moderate alopecia areata.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Food allergies may contribute to alopecia areata, and avoiding specific allergens can help hair regrowth.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Histopathological confirmation is crucial for accurately diagnosing challenging alopecia areata cases.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

The study concluded that a 'Swiss cheese' pattern in hair follicles is a useful sign for diagnosing alopecia areata.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Wrinkles form due to structural skin changes and vary in type and treatment response.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Some breast cancer chemotherapy can cause permanent hair loss.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.